University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Crizanlizumab (Adakveo®)
Status: Red Crizotinib
Status: Red Cytarabine–daunorubicin liposomal (Vyxeos®)
Status: Amber Dabigatran capsules

Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD

Adults only

Status: Red Dabrafenib
Status: Red Dabrafenib with trametinib
Status: Red Daclizumab concentrate for infusion

For Hospital Use Only. Please see drug safety alert.

Safety alert

Status: Red Dacomitinib
Status: Green Daktacort cream

Mild potency

Status: Green Dapagliflozin

For treating Type 2 diabetes in line with NICE 

Building healthier lives
Back to top